Tagged with strategy

Turkey Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish market. She provides her expert insights into current trends in the Turkish generics market and reinforces her company’s commitment to providing quality, affordable treatments.   I think that Turkey is one of the…

Turkey Uğur Bingöl, general manager of Ibrahim Etem Menarini, speaks of his company’s rapid growth and new product lines. He also describes his take on the Turkish pharmaceutical market and outlines his strategic priorities to continue growing Ibrahim Etem Menarini’s presence in Turkey.   We are committed to the localization movement…

Korea Paul Henry Huibers, president of Lilly Korea discusses Lilly’s strong double-digit growth following a challenging period of restructuring. Huibers offers his opinion on the pricing difficulties within the Korean market, emphasizing the importance of volume over price. He also concludes that Korea should focus on establishing itself as a leader…

Spain Carlos Rubió, executive president of Laboratorios Rubió, gives an overview of the company’s early years and his priorities now to make the company a larger player on the international scene. Furthermore, he highlights the need to increase the company´s size through JVs, possible M&As and US expansion, as well as…

Turkey * Dr Fabrizio Guidi has left his role as country chair & general manager Rx of Sanofi Turkey and is currently Sanofi’s general manager of diabetics and cardiovascular for Germany, Switzerland and Austria. From January 2019 Dr Guidi will become Sanofi’s general manager primary care GBU Germany, Switzerland and Austria and country…

Turkey Ismail Yormaz, vice president & regional director south-east at Recordati, shares the management secrets that have helped him grow Recordati into one of the top pharma companies in Turkey. He also shares his advice on navigating the Turkish market and his visions for the future.   Running a pharmaceutical company…

Malaysia Kshitij Panse, director of Servier Malaysia discusses the company’s planned move into oncology, as well as their strategies to provide an all-round improved patient experience, through education, screening, and e-health.   Oncology is the future, and we want to introduce the products in Servier’s pipeline to Malaysia as and when…

Canada John Fowler founded 7ACRES, a licensed producer of cannabis, in 2013. In 2014, 7ACRES went over to become part of The Supreme Cannabis Company, which today stands as a unique business model in the Canadian medical cannabis sector.   Indeed, The Supreme Cannabis Company operates as a wholesaler, a decision…

Algeria Doria Oughlis, Lilly’s GM for North West Africa, outlines the company’s historic presence in Algeria, current priorities and Lilly’s overarching contribution to the health of the region.   Could you please start by describing Lilly’s legacy in Algeria to date? Lilly’s presence in Algeria actually long predates the setting up…

Malaysia Javed Ghulam, CEO of AJ Research & Pharma, offers insights into the dynamic pharma industry in Malaysia and what it takes to be a competitive player in the region.   Being part of AJ Pharmaceuticals Holdings, what is the scope of operations specific to AJ Research & Pharma? AJ Research…

Algeria Guillaume Seillier, general director of Servier Algeria discusses recent changes in the affiliate, localization strategies, and Algeria’s importance to Servier’s regional and global operations.   We would like to reach 100 percent local production by 2020 Could you introduce the current face of Servier and the main changes and emerging…

Turkey Elif Çelik, executive vice president of the Healthcare Division of Eczacıbaşı Group, explains the rationale behind the group’s divestment of its generics arm and its new strategy to establish itself as a holistic healthcare organization, focused on bringing innovative solutions to Turkey through diverse partnership opportunities. Çelik also discusses the…